The U.S. Food and Drug Administration said on Tuesday it had approved the first COVID-19 self-testing kit for home use that provides results within 30 minutes.
The single-use test, made by Lucira Health, has been given emergency use authorization for home use with self-collected nasal swab samples in individuals age 14 and older who are suspected of COVID-19 by their health care provider, the FDA said.
“While COVID-19 diagnostic tests have been authorized for at-home collection, this is the first that can be fully self-administered and provide results at home,” FDA Commissioner Stephen Hahn said.
![Receive the latest medical news and health information delivered to you every Sunday.](https://globalnews.ca/wp-content/themes/shaw-globalnews/images/skyline/healthiq.jpg)
Get weekly health news
The kit can also be used at hospitals but samples should be collected by a healthcare provider if the individuals who are tested are younger than 14 years, the health regulator said.
![Click to play video: 'Coronavirus: Second wave hitting hard across Canada'](https://i0.wp.com/media.globalnews.ca/videostatic/news/7z5kkx5q0m-y5ot2ph4hs/web_canada_covid_pic.jpg?w=1040&quality=70&strip=all)
At home testing has not been authorized in Canada.
A post on Health Canada’s website says the agency has “authorized the sale and importation of COVID-19 tests only for use by health care professionals or trained operators.”
“However, we are open to reviewing all testing solutions,” the website reads. “This includes approaches that use self-testing kits, to enable individuals with or without symptoms to assess and monitor their own infections status.”
-With files from Global News
Comments